PURPOSE: This study aims to report our multicenter experience with diagnosis, management, and prognosis of anorectal gastrointestinal stromal tumors (GIST). PATIENTS AND METHODS: We retrospectively reviewed cases treated and/or followed up at our institutions in the period 2000-2011. RESULTS: Fifteen patients were identified (eight men and seven women; mean age, 55 years). Presenting symptoms were rectal/perirectal (eight), rectovaginal space (four), or retrovesical/prostatic (three) mass. Primary surgical treatment was local excision (six), deep anterior resection (eight), and palliative diagnostic excision (one). Tumor mean size was 4.8 cm. All but two cases were high risk (Miettinen and Lasota, Semin Diagn Pathol 23:70-83, 2006). R0 resection was achieved in 46% of cases: one of six local excisions vs. five of seven deep anterior resection (16 vs. 71%, respectively). All three cases who received total mesorectal excision had R0. Non-R0 status was mainly due to opening of tumor capsule at surgery (Rx). Seven of 14 patients (50%) developed ≥1 pelvic local recurrences at a mean period of 48.4 months (mean follow-up, 61.6 months). Only two patients developed distant metastasis (adrenal, liver, and peritoneal). Recurrences developed after Rx (three), R1 (two), and unknown R-status (two). Successful mutational analysis in 13 patients revealed KIT mutations in all (10 exon 11, 2 exon 9, and 1 exon 13). CONCLUSION: Our results confirm the high local recurrence rate of anorectal GISTs (50%) which correlates with the common practice of suboptimal oncological primary tumor resection (Rx or R1 = 7/13). This uncommon subset of GISTs needs more standardized oncological surgical approach to minimize the propensity for local disease recurrence.
PURPOSE: This study aims to report our multicenter experience with diagnosis, management, and prognosis of anorectal gastrointestinal stromal tumors (GIST). PATIENTS AND METHODS: We retrospectively reviewed cases treated and/or followed up at our institutions in the period 2000-2011. RESULTS: Fifteen patients were identified (eight men and seven women; mean age, 55 years). Presenting symptoms were rectal/perirectal (eight), rectovaginal space (four), or retrovesical/prostatic (three) mass. Primary surgical treatment was local excision (six), deep anterior resection (eight), and palliative diagnostic excision (one). Tumor mean size was 4.8 cm. All but two cases were high risk (Miettinen and Lasota, Semin Diagn Pathol 23:70-83, 2006). R0 resection was achieved in 46% of cases: one of six local excisions vs. five of seven deep anterior resection (16 vs. 71%, respectively). All three cases who received total mesorectal excision had R0. Non-R0 status was mainly due to opening of tumor capsule at surgery (Rx). Seven of 14 patients (50%) developed ≥1 pelvic local recurrences at a mean period of 48.4 months (mean follow-up, 61.6 months). Only two patients developed distant metastasis (adrenal, liver, and peritoneal). Recurrences developed after Rx (three), R1 (two), and unknown R-status (two). Successful mutational analysis in 13 patients revealed KIT mutations in all (10 exon 11, 2 exon 9, and 1 exon 13). CONCLUSION: Our results confirm the high local recurrence rate of anorectal GISTs (50%) which correlates with the common practice of suboptimal oncological primary tumor resection (Rx or R1 = 7/13). This uncommon subset of GISTs needs more standardized oncological surgical approach to minimize the propensity for local disease recurrence.
Authors: Elena Conca; Tiziana Negri; Alessandro Gronchi; Elena Fumagalli; Elena Tamborini; Giovanni Maria Pavan; Maurizio Fermeglia; Marco A Pierotti; Sabrina Pricl; Silvana Pilotti Journal: Mol Cancer Ther Date: 2009-09-01 Impact factor: 6.261
Authors: Antje-Friederike Pelz; Abbas Agaimy; Marc Daniels; Matthias Evert; Hans-Ulrich Schulz; Petra Lüders; Gudrun Müller; Jerzy Lasota; Albrecht Röpke; Peter Wieacker; Markku Miettinen; Regine Schneider-Stock Journal: Hum Pathol Date: 2011-01-14 Impact factor: 3.466
Authors: Jimmy Chak-Man Li; Simon Siu-Man Ng; Anthony Wing-Ip Lo; Janet Fung-Yee Lee; Raymond Ying-Chang Yiu; Ka-Lau Leung Journal: Indian J Gastroenterol Date: 2007 Jan-Feb
Authors: S Nagase; Y Mikami; T Moriya; H Niikura; K Yoshinaga; T Takano; K Ito; J Akahira; H Sasano; N Yaegashi Journal: Int J Gynecol Cancer Date: 2007-03-13 Impact factor: 3.437
Authors: Angela D Levy; Helen E Remotti; William M Thompson; Leslie H Sobin; Markku Miettinen Journal: AJR Am J Roentgenol Date: 2003-06 Impact factor: 3.959
Authors: Imran Hassan; Y Nancy You; Eric J Dozois; Roman Shayyan; Thomas C Smyrk; Scott H Okuno; John H Donohue Journal: Dis Colon Rectum Date: 2006-05 Impact factor: 4.585
Authors: T Ueki; K Nagayoshi; T Manabe; R Maeyama; A Yokomizo; H Yamamoto; Y Oda; M Tanaka Journal: Tech Coloproctol Date: 2014-12-31 Impact factor: 3.781
Authors: Michael J Cavnar; Lin Wang; Vinod P Balachandran; Cristina R Antonescu; William D Tap; Mary Keohan; Sam Singer; Larissa Temple; Garrett M Nash; Martin R Weiser; Jose G Guillem; Julio Garcia Aguilar; Ronald P DeMatteo; Philip B Paty Journal: Ann Surg Oncol Date: 2017-10-20 Impact factor: 5.344